Other Measurements
All patients underwent the following noninvasive examination and the following parameters were evaluated. On a 12-lead standard electrocardiograms (ECG) with a paper speed of 25 mm/s, we assessed the SV1+RV5, as an indicator of hypertrophy, QT dispersion (QTd) at rest, and ST-T depression over 0.1 mV during exercise (Ex ST-dep). We manually measured the QT interval in all leads. The end of the T wave was defined as a return to the isoelectric line. In the presence of the U wave, the QT interval was measured to the nadir between the T and U waves. Those leads in which the end of the T wave could not be measured because of a flat T wave or excessive noise were excluded. QTd was defined as the difference between maximal and minimal QT intervals. We also examined the presence of late potential (LP) in SAECG (FDX-6521, Fukuda Denshi, Tokyo, Japan) as described. 14 The thickness of the interventricular septum (IVS) and posterior wall (PW), and the end-diastolic and end-systolic diameters of the left ventricle (LVDd, LVDs) were measured by echocardiography (UCG). IVS, the ratio of IVS to PW (IVS/PW), LVDd and percent fractional shortening (%FS) were used as analytical parameters. Patients with HNCM and HOCM were classified by the type of hypertrophy according to the classification of Maron 16 using UCG. Total ventricular ectopic beats (VE), the maximal number of successive VE (max VE) and nonsustained ventricular tachycardia (NSVT ≥5 VEs) were evaluated by 24-h Holter monitoring, which was recorded a few days before the TWA assessment. We also investigated any family history of HCM (FH-HCM) or sudden death (FH-SD).
Twenty-two patients underwent right ventricular biopsy within 5 years of the TWA assessment for histopathological evaluation, as a score of 0-3 points, of the following: hypertrophy of myocytes, disarray and fibrosis. 17, 18 Two histopathologists first scored the micrographs independently and then evaluated the micrographs together and produced a common score. The mutational analysis of 7 disease genes proved so far to be associated were performed in 13 patients, as described previously, 19 at Tokyo Medical and Dental University.
Statistical Analysis
We compared all parameters between the patients with a positive TWA (TWA+ group) and the patients with negative TWA (TWA-group). ECG at rest, UCG and 24-h Holter monitoring data are expressed as means ± SD and were compared using an unpaired t-test between the TWA+ and TWA-groups. Other parameters were compared by the 2 test. Probability was considered significant at p<0.05.
Results

TWA, ECG, SAECG and UCG
T-wave alternans was positive in 27 (51%) and negative in 14 (26%) patients, and indeterminate in 12 (23%) because of too much noise or inadequate increase in heart rate. We excluded the indeterminate results from further analysis. The TWA+ and TWA-groups did not significantly differ in terms of age, sex, ECG and UCG parameters, and SAECG (Table 1) . 
24-h Holter Monitoring
Three of 5 patients who had experienced syncope were TWA+, but NSVT was not observed on Holter monitoring. The total VE did not significantly differ between the 2 groups, but max VE in the TWA+ group was significantly higher than that in the TWA-group (3.6±3.6 vs 1.3±0.7; p<0.05) ( Table 1) . Sustained VT and ventricular fibrillation were not observed. The ratio of patients with NSVT in the TWA+ group was also significantly higher than in the TWA-group (10/27, 37% vs 0/14, 0%; p<0.01). Therefore, the sensitivity, specificity, positive and negative predictive values, and predictive accuracy of TWA for NSVT were 100%, 45%, 37%, 100% and 59%, respectively. Those of QT dispersion ≥80 ms for NSVT were 50%, 35%, 20%, 69% and 39%, and those of LP were 10%, 87%, 20%, 75% and 68%, respectively.
Family History
Eight of 13 patients (62%) with a FH-HCM and 5 of 6 (83%) with a FH-SD were TWA+, but the incidence of FH-HCM and FH-SD did not significantly differ between the 2 groups (Table 1) .
Histopathological Analysis
Eleven patients were TWA+ and 6 were TWA-. The score of disarray was significantly higher in TWA+ than in the TWA-group (TWA+ vs TWA-was 1.9±1.1 vs 0.7±0.5 points; p<0.05), and the other scores of hypertrophy of myocytes and fibrosis were higher in the TWA+ group (Table 1) . Fig 1 shows representative data from a 66-yearold male patient. The IVS thickness was 18 mm and %FS was 42%. The 24-h Holter monitoring detected NSVT (max VE, 23), but he did not have a family history of HCM or sudden death. He was TWA+ with an onset heart rate of 98 beats/min. Histopathological assessment revealed mild myocytic hypertrophy with severe disarray and fibrosis. Table 2 shows the genetic analysis and clinical variables: 7 of 13 patients had genetic abnormalities (54%). Themyosin heavy chain (MYHC), cardiac muscle binding protein C (CMBPC) and troponin I (cTnI) were abnormal in 5, 1 and 1 patients, respectively. Case nos. 2 and 10 were brothers who did not have NSVT, but one was TWA+; nos. 7 and 13 were father and son, neither of whom had a genetic abnormality in the present analysis, but the son (case no. 7), who did not have NSVT, was TWA+; case nos. 3 and 9 both had NSVT and genetic abnormalities and both were TWA+. Of the patients with genetic abnormalities, only 1 (no. 10) was TWA+ without NSVT and the other 3 (nos. 2, 8, 11 and 12) did not have NSVT and were either TWA-or indeterminate. One patient with both a family history of sudden death and a genetic abnormality was TWA+ (no. 9).
Genetic Analysis
Discussion
Using noninvasive methods of identifying high-risk patients with HCM is an important priority. In the majority of studies of late potential (LP) using SAECG, the prevalence of LP was approximately 10%, with a higher incidence in patients with documented VT, although a significant correlation was not found. 7, [20] [21] [22] The prevalence of LP in those studies differed according to the filters and criteria used in the analysis; Chang et al suggested that the inability of SAECG to risk-stratify patients with HCM was probably because diffuse left ventricular hypertrophy masked the LP, or that sudden death in HCM is not caused by reentrant ventricular arrhythmias. 22 The QT dispersion (QTd) 8 and prolongation 23, 24 have also been reported in HCM: Buja et al reported that QT interval and QTd were significantly prolonged in HCM with ventricular tachyarrhythmia, 8 but Fananapazir et al suggested that prolongation of both the QT interval and QTd was a common finding in patients with HCM and may not be of prognostic significance in the absence of syncope or cardiac arrest. 24 The difficulty of determining the end of the T wave in HCM because of negative or biphasic T waves may be also limit its usefulness as a predictor.
We found that TWA was a more powerful method of identifying patients with VT than LP and QTd. Momiyama et al first reported TWA in patients with HCM, although the study population was extremely small and the correlation between TWA and the clinical variables of family history, cardiac function and histopathological change was not clarified. 12 Kon-no et al evaluated TWA in 12 patients with HCM and left ventricular hypertrophy (LVH), and reported that TWA may be related to abnormal myocardial arrangement (disarray) and/or fibrosis, although it was unclear how they determined the severity of fibrosis and disarray. 25 We evaluated the relationship between TWA and the histopathological changes quantitatively in 22 patients and also found that TWA correlated with myocardial disarray.
The present study evaluated the relationship between TWA and the conventional noninvasive risk predictors of sudden death and examined the clinical significance of TWA in 53 patients with HCM. Of the ECG variables, SV1+RV5 was higher in the TWA-group than in the TWA+ group, which we think is because several patients with complete right bundle branch block were included in TWA+ group. Maximal VE and NSVT on 24-h Holter monitoring closely correlated with TWA. A family history of HCM or sudden death weakly correlated with TWA. Therefore, TWA is a valuable tool for predicting sudden death in patients with HCM.
The present study also evaluated the TWA from the viewpoint of histopathological and genetic abnormalities. Patients with HCM and severe histopathological changes were TWA+, and of the histopathological changes that we examined, disarray closely correlated with TWA. Pastore et al reported that TWA is related to discordant alternans, which arises from the heterogeneity of the prolonged action potential in each myocyte. 26 Maron et al 27, 28 and McKenna et al 29 suggested that disorganized cells dispersed throughout the left ventricular wall are predisposed toward disordered electrical depolarization and repolarization, and constitute an arrythmogenic myocardial substrate. If a discordant area arises in the presence of disarray or fibrosis, then TWA will easily become positive. Yutani et al suggested that disarray was a characteristic histopathological change in HCM, involved in the decreasing diastolic function. 30 Thus, TWA could reflect histopathological changes, especially disarray, and provide useful information about the severity of HCM.
Apical hypertrophy is a type of HCM with good prognosis in which arrhythmia and decreased wall motion at the apex are observed rarely. 31 When our analyses excluded the 12 patients with APH, the results were same. Three of the APH patients had NSVT, 4 had a family history of HCM, and 3 had a family history of sudden death apparently caused by HCM. Therefore patients with APH should be evaluated for TWA.
The prognosis of familial HCM differs according to the genetic abnormalities and mutations. 32 For example, in families carrying the -MYHC gene, the Arg 403 Gln, Arg 453 Cys, Arg 719 Trp and Gly 716 Arg mutations are associated with a high incidence of sudden death in the young, whereas the Leu 908 Val and Val 606 Met mutations are associated with a near normal life expectancy. [33] [34] [35] The prognosis of families with MBPC is better than that of families with a malignant mutation in -MYHC. In families carrying cTnT, Arg 92 Trp and Ala 104 Val are associated with sudden death, although the hypertrophy is mild. 36, 37 In families with cTnI, the Lys 183 del mutation is associated with sudden death at any age and dilated cardiomyopathy-like features in those aged over 40. 38 We detected 6 different mutations in 7 patients, and TWA was positive in 2 patients with NSVT ( -MYHC and MBPC) and in 1 without NSVT ( -MYHC). One patient with an arginine mutation of -MYHC, which reportedly has a malignant prognosis, was TWA+, as was another with both a family history of sudden death and a genetic abnormality. The genetic abnormalities we found differed from those so far reported. The TWA+ patients without a genetic abnormality may have other unknown gene abnormalities. The relationship between TWA and genetic abnormalities remains unclear in these patients, and we need to carefully follow the changes in their clinical variables by Holter monitoring, UCG and TWA.
Study Limitations
Thirty-seven (78%) of the patients did not have obstructive HCM with which an abnormal blood pressure response, which is considered to be a predictor of a high risk of sudden death in HCM, is frequently associated. Prognosis is worse in the obstructive type, 2 so malignant and high-risk patients may not have been included in our study population because HCM patients with the severe obstructive type were excluded.
In addition, the relationship between a high risk of sudden death and genetic abnormalities remains unclear, especially with respect to the occurrence of ventricular tachyarrhythmia, and needs to be followed up in such patients.
Conclusions
In patients with HCM, TWA closely correlated with histopathological changes, especially disarray, and ventricular tachyarrhythmia, and may be a useful noninvasive marker for high-risk patients.
